ArticleAnti-cancer drugs2019

Preclinical testing of 5-amino-1-((1R,2S,3S,4R)-2,3-dihydroxy-4-methylcyclopentyl)-1H-imidazole-4-carboxamide: a potent protein kinase C-ι inhibitor as a potential prostate carcinoma therapeutic.

André H Apostolatos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.